Amryt Pharma Share Discussion Threads

[papillon] 27/8/2019 22:18

I would have topped up today, but I didn't know AMYT had relisted until I looked at this bb after the market had closed. Still there is always tomorrow.

At the moment I'm very bullish on AMYT. Don't let us poor ignorant sods down, Joe Wiley! Fingers crossed we see a much, much, higher share price in 12 months time. What I liked about AMYT was they made sure they had a revenue stream early on with Lojuxta. Joe Wiley seems like he wants more revenue, lots more, with the Aegerion acquisition. Compare that with PVR & LOGP!!

[richpassi] 27/8/2019 20:53

Very persuasive indeed as I thought that only a couple of weeks ago that chica had a relative who was using amryt products ....and didn't rate them !!! Forgive me if I'm wrong but I can't be bothered checking over old posts ....I hope this board doesn't turn into the likes of PVR And logp :(

[diamondstar1] 27/8/2019 18:40

Lara Cutlar - is that the same lady Bronxville met in a pub in Dublin, who convinced him to invest in some Amryt stock? Lara must be a very persuasive lady! Chica1 - you appear to be moving in the same circles as Bronxville. Or perhaps Chica1 = Bronxville. That’s an interesting thought!

[papillon] 27/8/2019 18:35

The share price closed at 105.5p. That's equivalent to 17.6p pre the 1 for 6 consolidation. A 43.5% increase on the pre suspension price of 12.25p.

I'm hopeful of a much higher share price by the time of the placing (and whether the RNS promised 148p will be achieved in practice), Aegerion acquisition and Nasdaq listing are finalised, hopefully in early Q4 2019. Also we have the phase III AP101 trial results to look forward to in early 2020.

Of course NOTHING on AIM is ever guaranteed, digadee. FINGERS CROSSED as always! However I'm hopeful on AMYT. I always have been, but that hope has been severely tested over the last 3 years. Fingers crossed AMYT now starts to perform and live up to my expectations.

[digadee] 27/8/2019 18:24

Lol, yes i know its not complete. My point is you like to give yourself a pat on the back when you get something right. What was the point of your post about the admission. Ohh look at me im so clever, pathetic reallyIts seems you seem to make enemies where ever u go on these boards. Where in my posts have i ramped ???You come across mr know it all and you like to remind folk that you got things right.

[papillon] 27/8/2019 18:17

I have news for you, digadee. The Aegerion takeover deal HASN'T yet gone through, digadee! I'm hopeful it will (it looks to be a certainty it will), but I never count my chickens until they are hatched. I always accept that nothing in life is ever guaranteed.

PS. alphabravo's recent post concerning the American court approval for the takeover made it 99% certain it would happen IMO, digadee. Unlike you (?) I base my opinions on the facts. I also NEVER ramp a share I'm invested in, so I prefer to take a more considered view of the future. I may be bullish on AMYT, but I don't want to be thought of as a RAMPER!

[digadee] 27/8/2019 17:55

Paps,You also doubted that the deal would go through....

[chica1] 27/8/2019 17:50

I bought 5000 shares just before close today because I met Lara Cutlar at a recent EB awareness day and she really impressed me.Its really only over .17 pence so I dont think I'm paying too much.
Hoping Gene therapy works whether it's be viral or non-viral.

[papillon] 27/8/2019 17:45

In this post, papillon 5 Aug '19 - 19:44 - 4701 of 4737, I suggested that "Hence it's possible that AMYT could relist as soon the admission document is published in "early August" and before the Aegerion deal is finalised." That's what has happened today, but in late, not early August. I suggested this might happen because this happened with FAST when it acquired AMYT.

[delta0091] 27/8/2019 16:41

The CVR scenario is quite interesting.

If i've read it correctly if amryt hits targets for 2022 and 2024.... shareholders will get equivalent of 1 extra share @ £1.28 for every share held.. The CVR Record Date is 20 September 2019.

[waterloo01] 27/8/2019 15:49

Quite right, I wasn't sure so thanks. Looking forward to the broker notes and press.

[sidam] 27/8/2019 15:41

The consolidation was 1 for 6, so 100p now would be 16.66 pre consolidation.

Admission document makes interesting reading. There are projections for the acquired business indicating significant net income in 2020 and thereafter.

Also some timing for the payments (3 tranches) to old shareholders. Together with the revenue targets for one payment and possible date for approval of AP101.

If all works out, shareholders will get current price back in cash plus their share of the upside in a potentially very interesting group. And not that far away.

Read the document page 486 in part 3 for projections.

Good luck.

[dlm2602] 27/8/2019 15:36

Divide the current price by 6

[bermudashorts] 27/8/2019 15:25

Probably being thick here Waterloo but isn't it nearer 18p to 19p?

[waterloo01] 27/8/2019 15:14

With the consolidation it's trading at 13p ish (old money) I think

[barnes4] 27/8/2019 13:48

The ole pi

[alphabravo321] 27/8/2019 13:04

We are back

[bermudashorts] 25/8/2019 08:44

Recent abstract on efficacy of Lojuxta/Juxtapid


Conclusions

Treatment with lomitapide in homozygous familial hypercholesterolaemia patients has a beneficial effect with a constant decrease of low-density lipoprotein cholesterol by 57% compared with classical lipid-lowering therapy and by 54% compared with classical lipid-lowering therapy and time-averaged level of low-density lipoprotein cholesterol.

[alphabravo321] 25/8/2019 08:21

https://epidermolysisbullosanews.com/2019/08/16/amryt-oleogel-s10-phase-3-trial-design-epidermolysis-bullosa/

[bazworth] 23/8/2019 20:40

Could someone give me a nudge please when we’re up and running again. I think I may kick myself for substantially reducing, hey ho!!